Non-CpG Methylation of the PGC-1α Promoter through DNMT3B Controls Mitochondrial Density
Non-CpG Methylation of the PGC-1α Promoter through DNMT3B Controls Mitochondrial Density
复制标题
DOI:
10.1016/j.cmet.2009.07.011
复制
发表时间:
2009-09-02
期刊:
影响因子:
29
通讯作者:
Zierath, Juleen R.
中科院分区:
文献类型:
--
作者:
Barres, Romain;Osler, Megan E.;Zierath, Juleen R.
Epigenetic modification through DNA methylation is implicated in metabolic disease. Using whole-genome promoter methylation analysis of skeletal muscle from normal glucose-tolerant and type 2 diabetic subjects, we identified cytosine hypermethylation of peroxisome proliferator-activated receptor gamma (PPAR gamma) coactivator-1 alpha (PGC-1 alpha) in diabetic subjects. Methylation levels were negatively correlated with PGC-1 alpha mRNA and mitochondrial DNA (mtDNA). Bisulfite sequencing revealed that the highest proportion of cytosine methylation within PGC-1 alpha was found within non-CpG nucleotides. Non-CpG methylation was acutely increased in human myotubes by exposure to tumor necrosis factor-alpha (TNF-alpha) or free fatty acids, but not insulin or glucose. Selective silencing of the DNA methyltransferase 3B (DNMT3B), but not DNMT1 or DNMT3A, prevented palmitate-induced non-CpG methylation of PGC-1 alpha and decreased mtDNA and PGC-1 alpha mRNA. We provide evidence for PGC-1 alpha hypermethylation, concomitant with reduced mitochondrial content in type 2 diabetic patients, and link DNMT3B to the acute fatty-acid-induced non-CpG methylation of PGC-1 alpha promoter.